Latest Famotidine News & Updates

New Delhi, July 11 (IANS) The Maharashtra Food and Drug Administration (FDA) has barred the sale and distribution of certain medicines manufactured by Cadila Pharmaceuticals Ltd and seized stock worth around Rs 2.45 crore over concerns that similar branding could lead to medication errors, as per multiple reports.It also directed the company to recall select products from the market, it added.The action relates to Aciloc 150, Aciloc 150 Plus, Aciloc 300 and Aciloc 300 Plus, which contain differe…